Lv7
4980 积分 2022-03-17 加入
Life-threatening multiorgan immune-related toxicities complicated by sepsis after anti-PD-1 therapy with complete tumor regression: a case report and literature review
2小时前
已完结
Abstract GS01-02: Phase 3 study of neoadjuvant pembrolizumab or placebo plus chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/HER2− breast cancer: KEYNOTE-756
8天前
已关闭
Nivolumab for Resected Stage III or IV Melanoma at 9 Years
9天前
已完结
[Chinese clinical practice guidelines for transarterial interventions of hepatocellular carcinoma (2026 edition)]
13天前
已完结
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
1个月前
已完结
Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden‐High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment
1个月前
已关闭
Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts
1个月前
已完结
Efficacy and safety of loxoprofen sodium topical patch for the treatment of pain in patients with minor acute traumatic limb injuries in Brazil: a randomized, double-blind, noninferiority trial
1个月前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
2个月前
已完结
皖公网安备34019202002308
